Form 483

Eurofins Donor & Product Testing LLC Form 483, 2010-05-28

FDA issued a Form 483 to Eurofins Donor & Product Testing LLC on 2010-05-28 with 7 public-safe observations.

483· Form 483 issued7 observations

Eurofins Donor & Product Testing LLC · Centennial, United States · Issued May 28, 2010

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 May 2010
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Marc A Jackson, Theressa B Smith

28 May 2010
21 CFR 606.65(e)

Following manufacturer's instructions

Cited by Marc A Jackson, Theressa B Smith

28 May 2010
21 CFR 606.100(b)(14)

QC procedures for supplies and reagents

Cited by Marc A Jackson, Theressa B Smith

28 May 2010
21 CFR 606.100(c)

Thorough investigations

Cited by Marc A Jackson, Theressa B Smith

28 May 2010
21 CFR 606.160(a)(1)

Person performing, test results, interpretation

Cited by Marc A Jackson, Theressa B Smith

Inspected site

EDEurofins Donor & Product Testing LLCCentennial, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)(14)Cited across public-safe Form 483 observations1x
21 CFR 606.100(c)Cited across public-safe Form 483 observations1x
21 CFR 606.160(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 606.160(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 606.65(e)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere